1 Pfizer's New Treatment Elranatamab Receives FDA Breakthrough Therapy Designation For Relapsed Or Refractory Multiple Myeloma May 12, 2025
Read More Medical Neratinib Included In NCCN Guidelines For Specific HER2-Negative Breast Cancers May 17, 2025
Read More Apparatus Canada has developed a hand-held detector to help reduce the use of antibiotics May 12, 2025
